Comparison of coronary artery bypass grafting and stenting depending on the clinical and anatomical scenario: data from the retrospective single-center cohort study
Open Access
- 20 May 2025
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (4) , 6092
Abstract
Aim. To assess the long-term all-cause mortality after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with stable coronary artery disease (CAD) under various clinical and anatomical scenarios.Material and methods. This single-center cohort retrospective study assessed the outcomes of CABG and PCI with implantation of second-generation drugeluting stents in 4177 patients with stable CAD. Inhospital, 30-day and remote 5-year all-cause mortality (mean follow-up period — 38 months) was assessed. Also, the influence of the initial severity of CAD, the presence/absence of diabetes, myocardial contractility on remote all-cause mortality after myocardial revascularization was assessed.Results. Inhospital and 30-day risks of death in patients who underwent PCI and CABG, after comparing the initial clinical characteristics, did not differ significantly. In the long-term follow-up period, PCI compared with CABG was associated with an increased all-cause mortality in the main groups (PCI vs CABG: odds ratio (OR) 1,84, 95% confidence interval (CI) 1,30-2,62, p50% (OR 5,04, 95% CI 1,72-14,76, p=0,003), but not in patients with single-vessel disease (OR 2,084, 95% CI 0,9964,361, p=0,051). Diabetes in the main study groups did not affect the difference in mortality as follows: CABG had an advantage over PCI regardless of diabetes. However, CABG in patients with multivessel disease and diabetes, in contrast to patients without diabetes, led to a significant decrease in all-cause death risk (OR 2,29, 95% CI 1,173-4,47, p=0,015). Also, PCI compared with CABG was accompanied by an increase in the 5-year death risk in patients with an not reduced left ventricular ejection fraction (LVEF) >40% (OR 1,74, 95% CI 1,205-2,536, p=0,003), but not in patients with LVEF 50%, lesion of two or more coronary arteries), with concomitant diabetes in multivessel disease, and patients with non-reduced LVEF (>40%).Keywords
This publication has 17 references indexed in Scilit:
- Percutaneous coronary intervention versus coronary artery surgery for left main disease according to lesion site: A meta-analysisThe Journal of Thoracic and Cardiovascular Surgery, 2023
- Myocardial revascularization in chronic coronary artery disease. State of artKardiologiia, 2023
- Percutaneous Revascularization for Ischemic Left Ventricular DysfunctionNew England Journal of Medicine, 2022
- Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery diseaseEuropean Heart Journal, 2021
- 2020 Clinical practice guidelines for Stable coronary artery diseaseRussian Journal of Cardiology, 2020
- Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery DiseaseCirculation, 2019
- Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery DiseaseCirculation: Heart Failure, 2017
- Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary DiseaseNew England Journal of Medicine, 2015
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseNew England Journal of Medicine, 2013
- Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)European Heart Journal, 2012